n represents number of participants with baseline and post-baseline value at Week 48
Additional findings are due to be published in peer-reviewed journals and presented at the 86th annual American Diabetes Association Scientific Sessions, held in June 2026 in New Orleans, Louisiana, United States
Any differences relate to individual caffeine sensitivity, which depends on personal tolerance rather than gender
By AestheticsRx Pharma June 4th, 2026 By AestheticsRx Pharma May 28th, 2026 By AestheticsRx Pharma May 19th, 2026 By AestheticsRx Pharma May 15th, 2026 By AestheticsRx Pharma May 8th, 2026 By AestheticsRx Pharma April 30th, 2026 By AestheticsRx Pharma December 16th, 2025 By AestheticsRx Pharma December 1st, 2025 By AestheticsRx Pharma August 12th, 2025 By AestheticsRx Pharma July 11th, 2025 By AestheticsRx Pharma March 1st, 2025
Subscribe today
Ideally, the company will clearly state what the test cannot dosuch as diagnosing a specific disease, replacing standard medical screening, or serving as the sole basis for treatment decisions